Načítá se...
Risks and Benefits of Magnesium Sulfate Tocolysis in Preterm Labor (PTL)
The U.S. Food and Drug Administration issued a drug safety communication on 05/30/2013 recommending “against prolonged use of magnesium sulfate to stop preterm labor (PTL) due to bone changes in exposed babies.” In September of 2013, The American Congress of Obstetrics and Gynecologists issued Commi...
Uloženo v:
| Vydáno v: | AIMS Public Health |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
AIMS Press
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5690360/ https://ncbi.nlm.nih.gov/pubmed/29546168 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3934/publichealth.2016.2.348 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|